In a cross-sectional study including 106 patients with PCOS and 60 controls from Argentina, patients were classified as showing a hyperandrogenic (in presence of signs of biochemical and/or clinical hyperandrogenism) or normoandrogenic phenotype, and serum chemerin levels were assessed [47]. The gene discussed is RARRES2; the disease is polycystic ovary syndrome.